Celldex Therapeutics | CLDX - Créances Commerciales





Créances Commerciales Changement Date
AbbVie USD 12.48B 110M 2026-03
Agenus USD 22.34M 107K 2026-03
Amgen USD 10.23B 1.09B 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Celldex Therapeutics USD 230K 0 2026-06
Glaxosmithkline GBP 10.49B 40.6M 2026-03
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Northwest Biotherapeutics USD 311K 299K 2025-09
Pfizer USD 16.19B 19M 2026-06
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Roche Holding CHF 13.34B 1.44B 2026-06